MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Adbry ™ (tralokinumab-ldrm) for the treatment of moderate-to-severe atopic ...
If you have atopic dermatitis, a skin condition commonly known as eczema, prescription creams or other topical medicines and moisturizers are usually enough to manage it. However, if your eczema is ...
Adbry (tralokinumab-ldrm) is a prescription drug that’s used to treat atopic dermatitis (eczema). Adbry comes as a liquid solution that you inject under your skin. Adbry is used in adults and certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback